These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3302116)

  • 1. Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid alpha-glucosidase.
    van der Ploeg AT; Kroos M; van Dongen JM; Visser WJ; Bolhuis PA; Loonen MC; Reuser AJ
    J Neurol Sci; 1987 Jul; 79(3):327-36. PubMed ID: 3302116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine generalised glycogenosis type II. Uptake of lysosomal alpha-glucosidase by cultured skeletal muscle and reversal of glycogen accumulation.
    Di Marco PN; Howell JM; Dorling PR
    FEBS Lett; 1985 Oct; 190(2):301-4. PubMed ID: 3899727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.
    Umapathysivam K; Hopwood JJ; Meikle PJ
    Clin Chim Acta; 2005 Nov; 361(1-2):191-8. PubMed ID: 15993875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle.
    Van der Ploeg AT; Loonen MC; Bolhuis PA; Busch HM; Reuser AJ; Galjaard H
    Pediatr Res; 1988 Jul; 24(1):90-4. PubMed ID: 2970619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease.
    Van Hove JL; Yang HW; Wu JY; Brady RO; Chen YT
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):65-70. PubMed ID: 8552676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult forms of glycogenosis type II. A defect in an early stage of acid alpha-glucosidase realization.
    Reuser AJ; Kroos M
    FEBS Lett; 1982 Sep; 146(2):361-4. PubMed ID: 6754447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.
    Yi H; Sun T; Armstrong D; Borneman S; Yang C; Austin S; Kishnani PS; Sun B
    J Mol Med (Berl); 2017 May; 95(5):513-521. PubMed ID: 28154884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and stability of human and bovine acid alpha-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patients.
    Reuser AJ; Kroos MA; Ponne NJ; Wolterman RA; Loonen MC; Busch HF; Visser WJ; Bolhuis PA
    Exp Cell Res; 1984 Nov; 155(1):178-89. PubMed ID: 6237928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K; Gröbe H; Korinthenberg R; von Bassewitz DB
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation.
    Nicolino MP; Puech JP; Kremer EJ; Reuser AJ; Mbebi C; Verdière-Sahuqué M; Kahn A; Poenaru L
    Hum Mol Genet; 1998 Oct; 7(11):1695-702. PubMed ID: 9736771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical, immunological, and cell genetic studies in glycogenosis type II.
    Reuser AJ; Koster JF; Hoogeveen A; Galjaard H
    Am J Hum Genet; 1978 Mar; 30(2):132-43. PubMed ID: 350041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal glycogen storage disease with normal acid maltase.
    Danon MJ; Oh SJ; DiMauro S; Manaligod JR; Eastwood A; Naidu S; Schliselfeld LH
    Neurology; 1981 Jan; 31(1):51-7. PubMed ID: 6450334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts.
    Yang HW; Kikuchi T; Hagiwara Y; Mizutani M; Chen YT; Van Hove JL
    Pediatr Res; 1998 Mar; 43(3):374-80. PubMed ID: 9505277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apparent activity in vivo of the lysosomal pathway of glycogen catabolism in cultured human skin fibroblasts from patients with type III glycogen storage disease.
    Brown DH; Waindle LM; Brown BI
    J Biol Chem; 1978 Jul; 253(14):5005-11. PubMed ID: 353046
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells.
    van der Ploeg AT; Bolhuis PA; Wolterman RA; Visser JW; Loonen MC; Busch HF; Reuser AJ
    J Neurol; 1988 Sep; 235(7):392-6. PubMed ID: 3065462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lysosomal glycogen storage in lymphocytes in patients with glycogenosis type II].
    Gröbe H; von Bassewitz DB; Bremer HJ; Bourgeois M
    Monatsschr Kinderheilkd (1902); 1976 May; 124(5):419-20. PubMed ID: 1064747
    [No Abstract]   [Full Text] [Related]  

  • 17. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.
    Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD
    Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal enzyme replacement using alpha 2-macroglobulin as a transport vehicle.
    Tsuji A; Oda R; Sakiyama K; Nagamune H; Itoh K; Kase R; Sakuraba H; Suzuki Y; Matsuda Y
    J Biochem; 1994 May; 115(5):937-44. PubMed ID: 7525546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.
    Basile I; Da Silva A; El Cheikh K; Godefroy A; Daurat M; Harmois A; Perez M; Caillaud C; Charbonné HV; Pau B; Gary-Bobo M; Morère A; Garcia M; Maynadier M
    J Control Release; 2018 Jan; 269():15-23. PubMed ID: 29108866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.